Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
Organisation › Details

Etherna N.V.

eTheRNA immunotherapies NV is developing immunotherapy and vaccine products for the treatment of cancer and infectious disease from its mRNA chemistry, antigen identification, lipid chemistry and delivery and process engineering platforms. The company is headquartered in Belgium and was established in 2013. Its founding shareholders include Progress Pharma and VUB. eTheRNA is supported by an international group of specialised investors; BNP Fortis Private Equity, Boehringer Ingelheim Venture Funds, Everjoy Fortune PTE. LTD, Grand Decade Development Limited, Fund+, LSP, Novalis Lifesciences, Omega Funds, PMV and Ying Zhou Enterprise Management Company Limited who share the Company’s ambition to build a world-leading company in the RNA field. To date, the Company has raised €63 million of venture funding. *

 

Period Start 2023-10-17 renamed date ca
  Group Etherna (Group)
  Predecessor Etherna Immunotherapies N.V.
Products Industry mRNA technology
  Industry 2 lipid nanoparticle technology (LNP technology)
Persons Person Sagaert, Bernard (eTheRNA 202208– Interim-CEO before COO)
  Person 2 Dekkers, Marijn E. (Novalis LifeSciences 202208 Chairman + Founder before Bayer CEO + Thermo Fisher CEO)
     
Region Region Belgium_oo
  Country Belgium
  Street Galileilaan
  City 2845 Niel
    Address record changed: 2024-07-20
     
Basic data Employees A: 1 to 10
     
    * Document for »About Section«: eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel.
     
   
Record changed: 2024-07-20

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Etherna (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Global Village 2025 Basel 650x300px




» top